Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
NLS Pharmaceutics AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
NLS Pharmaceutics AG Earnings Date And Information
NLS Pharmaceutics AG last posted its earnings results on Wednesday, May 15th, 2024. The company reported $-0.00014 earnings per share for the quarter, topping analysts' consensus estimates of $-8.4 by $8.39986. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NLS Pharmaceutics AG has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -27.75. NLS Pharmaceutics AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based on prior year's report dates.
NLS Pharmaceutics AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/18/2024 | Q2 2024 | N/A | $0.00 | N/A | $0 | $0 |
| 05/15/2024 | Q4 2023 | -$8.40 | -$0.14 | 8.26 | $0 | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.20 | N/A | N/A | $0 |
| 05/05/2023 | Q4 2022 | -$12.00 | -$0.29 | 11.71 | N/A | $0 |
| 10/11/2022 | Q2 2022 | N/A | -$0.54 | N/A | N/A | $0 |
| 03/24/2022 | Q4 2021 | -$13.80 | -$0.50 | 13.3 | N/A | $0 |
| 09/28/2021 | Q2 2021 | N/A | -$0.42 | N/A | N/A | $0 |
| 05/14/2021 | Q4 2020 | -$6.80 | -$0.34 | 6.46 | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.11 | N/A | N/A | $0 |
| 12/30/2019 | Q4 2019 | N/A | -$0.18 | N/A | N/A | $0 |
| 06/29/2019 | Q2 2019 | N/A | -$0.31 | N/A | N/A | $0 |
| 12/30/2018 | Q4 2018 | N/A | -$19.32 | N/A | N/A | $0 |
| 06/29/2018 | Q2 2018 | N/A | -$13.57 | N/A | N/A | $0 |
| 06/29/2017 | Q2 2017 | N/A | -$0.16 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NLS Pharmaceutics AG Earnings: FAQ's
NLS Pharmaceutics AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 21st, 2025 based offlast year's report dates.
In the previous quarter, NLS Pharmaceutics AG (:NLSP) reported $-0.00014 earnings per share (EPS) to beat the analysts' consensus estimate of $-8.4 by $8.39986.
The conference call for NLS Pharmaceutics AG's latest earnings report can be listened to online.
The conference call transcript for NLS Pharmaceutics AG's latest earnings report can be read online.
NLS Pharmaceutics AG (:NLSP) has a recorded net income of $-12,172,029.NLS Pharmaceutics AG has generated $-0.32 earnings per share over the last four quarters.
NLS Pharmaceutics AG (:NLSP) has a price-to-earnings ratio of -27.75 and price/earnings-to-growth ratio is -0.47.